Whole‐mount analysis reveals normal numbers of dopaminergic neurons following misexpression of α‐Synuclein in Drosophila

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Genesis

• Publication date

  2005-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/gene.20106PMID 15789427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuronal !-Synucleinopathy with Severe Movement Disorder in Mice Expressing A 53 T Human !-Synuclein

  2007cited by this paper
• Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress

  2004cited by this paper
• GAL4 causes developmental defects and apoptosis when expressed in the developing eye of Drosophila melanogaster.

  2003cited by this paper
• Drosophila retinal homeobox (drx) is not required for establishment of the visual system, but is required for brain and clypeus development.

  2003cited by this paper
• Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila.

  2003influential reference
• Pharmacological prevention of Parkinson disease in Drosophila

  2002influential reference
• Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.

  2002cited by this paper
• Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster.

  2002cited by this paper
• Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.

  2002cited by this paper
• Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice

  2002cited by this paper
• Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.

  2002cited by this paper
• Dopamine and sensory tissue development in Drosophila melanogaster.

  2001cited by this paper
• Lack of Nigral Pathology in Transgenic Mice Expressing Human α-Synuclein Driven by the Tyrosine Hydroxylase Promoter

  2001cited by this paper
• Dbest1, a drosophila homolog of human bestrophin, is not required for viability or photoreceptor integrity

  2001influential reference
• Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease

  2001cited by this paper
• Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease

  2001influential reference
• Ectopic G-protein expression in dopamine and serotonin neurons blocks cocaine sensitization in Drosophila melanogaster.

  2000cited by this paper
• Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.

  2000cited by this paper
• A Drosophila model of Parkinson's disease

  2000influential reference
• Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

  1998cited by this paper
• Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

  1997cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• dachshund encodes a nuclear protein required for normal eye and leg development in Drosophila.

  1994cited by this paper
• Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.

  1993cited by this paper
• Catecholamine‐containing neurons in Drosophila melanogaster: Distribution and development

  1988cited by this paper

• Modeling neurodegenerative diseases in Drosophila is conditioned by stress resistance and gut microbiome composition of the reference line

  2025cites this paper
• Altered reactivity to threatening stimuli in Drosophila models of Parkinson’s disease, revealed by a trial-based assay

  2025cites this paper
• From Flies to Findings:The Function of Insect Models in Predicting Protein Function and Neurodegenerative Disease

  2025influential citation
• A Simple Immunofluorescence Method to Characterize Neurodegeneration and Tyrosine Hydroxylase Reduction in Whole Brain of a Drosophila Model of Parkinson’s Disease

  2024cites this paper
• A Quick and Laidback Way to Detect the Internal Structure of the Drosophila Eye: An Alternative to Cryosectioning.

  2023cites this paper
• Fluorescence microscopy-based sensitive method to quantify dopaminergic neurodegeneration in a Drosophila model of Parkinson’s disease

  2023cites this paper
• Altered reactivity to threatening stimuli in Drosophila models of Parkinson’s disease , revealed by a trial-1 based assay 2

  2023cites this paper
• Adult health and transition stage-specific rotenone-mediated Drosophila model of Parkinson’s disease: Impact on late-onset neurodegenerative disease models

  2022cites this paper
• Reduction of the α-synuclein expression promotes slowing down early neuropathology development in the Drosophila model of Parkinson’s disease

  2022cites this paper
• Roles of α-Synuclein and Disease-Associated Factors in Drosophila Models of Parkinson’s Disease

  2022cites this paper
• Parkin Knockdown Modulates Dopamine Release in the Central Complex, but Not the Mushroom Body Heel, of Aging Drosophila.

  2022cites this paper
• Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases

  2020cites this paper
• Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases – ERRATUM

  2020cites this paper
• Mutations in CHCHD2 cause α-synuclein aggregation.

  2019cites this paper
• Genetically engineered animal models of Parkinson's disease: From worm to rodent

  2019cites this paper
• Cross-species models of attention-deficit/hyperactivity disorder and autism spectrum disorder: lessons from CNTNAP2, ADGRL3, and PARK2

  2018cites this paper
• Modeling Parkinson’s Disease in Drosophila: What Have We Learned for Dominant Traits?

  2018cites this paper
• Drosophila as a Neurotoxicological Model

  2018cites this paper
• α-Synuclein Trafficking in Parkinson’s Disease: Insights From Fly and Mouse Models

  2018cites this paper
• Drosophila Models of Sporadic Parkinson’s Disease

  2018cites this paper
• Orobol derivatives and extracts from Cudrania tricuspidata fruits protect against 6-hydroxydomamine-induced neuronal cell death by enhancing proteasome activity and the ubiquitin/proteasome-dependent degradation of α-synuclein and synphilin-1

  2017cites this paper
• Auxilin Underlies Progressive Locomotor Deficits and Dopaminergic Neuron Loss in a Drosophila Model of Parkinson's Disease.

  2017cites this paper
• Effects of small-molecule amyloid modulators on a Drosophila model of Parkinson’s disease

  2017cites this paper
• Effect of Myricetin on the Oxidative Stress Markers in the Brain of Transgenic Flies Expressing Human Alpha-Synuclein

  2017cites this paper
• Developmental analysis of the dopamine‐containing neurons of the Drosophila brain

  2017cites this paper
• Drosophila Clock Is Required in Brain Pacemaker Neurons to Prevent Premature Locomotor Aging Independently of Its Circadian Function

  2017cites this paper
• Evaluation of Models of Parkinson's Disease

  2016cites this paper
• Analysis of dopaminergic neuronal dysfunction in genetic and toxin‐induced models of Parkinson's disease in Drosophila

  2014cites this paper
• Neuroprotection of Dopaminergic Neurons and their Subcellular Structures from Parkinson's Disease-like Treatment

  2014cites this paper
• A new Drosophila model to study the interaction between genetic and environmental factors in Parkinson's disease.

  2014cites this paper
• Animal Models for Huntington's and Parkinson's Diseases

  2013cites this paper
• Selective degeneration of dopaminergic neurons by MPP+ and its rescue by D2 autoreceptors in Drosophila primary culture

  2013influential citation
• Animal models of Parkinson’s disease and related disorders

  2013cites this paper
• Elucidating the role of post-translational modifications of alpha-synuclein using semisynthesis

  2012cites this paper
• Drosophila Models of Proteinopathies: the Little Fly that Could

  2012cites this paper
• Mécanismes moléculaires et de signalisation induits par le stress oxydatif dans des modèles in vivo de la maladie de Parkinson chez la drosophile : intoxication au paraquat et expression de l'α-synucléine

  2012cites this paper
• Drosophila models of Parkinson's disease.

  2011influential citation
• Drosophila Models of Parkinson's Disease: Discovering Relevant Pathways and Novel Therapeutic Strategies

  2011cites this paper
• Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

  2011cites this paper
• Zebrafish as a Model for the Study of Parkinson’s Disease

  2011cites this paper
• Modulation of Oxidative Stress by Keap1/Nrf2 Signaling in Drosophila: Implications for Human Diseases

  2011cites this paper
• Suppression of Nrdp1 toxicity by Parkin in Drosophila models.

  2011cites this paper
• Human Disease Models in Drosophila melanogaster and the Role of the Fly in Therapeutic Drug Discovery

  2011cites this paper
• Drosophila Melanogaster as a Model Organism for Dementia

  2011cites this paper
• Extended lifespan of Drosophila parkin mutants through sequestration of redox-active metals and enhancement of anti-oxidative pathways.

  2010cites this paper
• Drosophila melanogaster in the Study of Human Neurodegeneration

  2010cites this paper
• Interactions of LRRK2 in a Drosophila melanogaster model of Parkinson's disease

  2010cites this paper
• Identification and Analysis of Gene Product Modifiers of α-Synuclein Toxicity in the Fruit Fly (D. Melanogaster).

  2010cites this paper
• dGIPC is required for the locomotive activity and longevity in Drosophila.

  2010cites this paper
• Neurodegenerative models in Drosophila: polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis.

  2010cites this paper
• Genetic animal models of Parkinson's disease.

  2010cites this paper
• The Dopaminergic System in the Aging Brain of Drosophila

  2010cites this paper
• The Therapeutic Potential of LRRK2 and α-Synuclein in Parkinson's Disease

  2009cites this paper
• Modelling Parkinson’s Disease in Drosophila

  2009cites this paper
• Molecular mechanisms of alpha-synuclein neurodegeneration.

  2009cites this paper
• Treating Oxidative Neural Injury: Methionine Sulfoxide Reductase Therapy for Parkinson’s Disease

  2009cites this paper
• Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease

  2009cites this paper
• Drosophila models of neurodegenerative diseases.

  2009cites this paper
• α-Synuclein and neuronal cell death

  2009cites this paper
• Genetic models of Parkinson disease.

  2009cites this paper
• Superoxide dismutase overexpression protects dopaminergic neurons in a Drosophila model of Parkinson's disease.

  2008cites this paper
• An Optimized Method for Histological Detection of Dopaminergic Neurons in Drosophila melanogaster

  2008influential citation
• InductionofthePhaseIIDetoxificationPathwaySuppresses NeuronLossinDrosophilaModelsofParkinson'sDisease

  2008cites this paper
• Drosophila and Parkinson's Disease: The effects of various stressors on alpha-synuclein transgenic flies

  2008cites this paper
• Induction of the Phase II Detoxification Pathway Suppresses Neuron Loss in Drosophila Models of Parkinson's Disease

  2008cites this paper
• Aggregated α-Synuclein Mediates Dopaminergic Neurotoxicity In Vivo

  2007cites this paper
• Methionine Sulfoxide Reductase A and a Dietary Supplement S-Methyl-L-Cysteine Prevent Parkinson's-Like Symptoms

  2007cites this paper
• Overexpression of Septin 4, the Drosophila homologue of human CDCrel‐1, is toxic for dopaminergic neurons

  2007cites this paper
• Drosophila melanogaster neurobiology, neuropharmacology, and how the fly can inform central nervous system drug discovery.

  2006cites this paper
• HistamineandItsReceptorsModulateTemperature- PreferenceBehaviorsinDrosophila Sung-TaeHong,SunhoeBang,DonggiPaik,JongkyunKang,SeungyoonHwang,KeunhyeJeon,BumkooChun, SeogangHyun,YoungseokLee,andJaeseobKim

  2006cites this paper
• Histamine and Its Receptors Modulate Temperature-Preference Behaviors in Drosophila

  2006cites this paper
• Drosophila models pioneer a new approach to drug discovery for Parkinson's disease.

  2006cites this paper
• Selective loss of dopaminergic neurons and formation of Lewy body‐like aggregations in α‐synuclein transgenic fly neuronal cultures

  2006cites this paper
• Lessons from Drosophila models of DJ-1 deficiency.

  2006cites this paper
• Drosophila models of neurodegenerative disease

  2005cites this paper